Latest Breaking News On - European renal association - Page 1 : comparemela.com

Hematology Month in Review: May 2024

Our May 2024 month-in-review for hematology focuses on important FDA updates, new anemia data from ERA 2024, and the latest imaging modalities.

How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?

The experimental IL-6 inhibitor clazakizumab improves key inflammation markers in one study, whereas another shows lower risks with home hemodialysis vs peritoneal dialysis.

Peroxiredoxins Linked to Kidney Function Decline in IgA Nephropathy

Results suggest certain peroxiredoxins may be viable prognostic markers in glomerulopathies, including IgA nephropathy and membranous nephropathy.

Ozempic and Wegovy could double as kidney disease treatment, study suggests

GlobalData : IGNAZ trial interim results highlight HI-Bio's potential to differentiate in IgAN space, says GlobalData

31 May, 2024 IGNAZ trial interim results highlight HI-Bio s potential to differentiate in IgAN space, says GlobalData Share .